Results
1 -
8 of
8
(Click
here to explore results)
- Discovery of novel chemical scaffolds as RhoA inhibitors using virtual screening, synthesis, and bioactivity evaluation. Chao Zhang, Hui-Jie Wang, Qi-Chao Bao, Jin-Lei Bian, Ying-Rui Yang, Qi-Dong You, Xiao-Li Xu
, RSC Adv.
, 2016
, 6
, 56738
- An aryne-based three-component access to α-aroylamino amides. Marta Serafini, Alessia Griglio, Sara Viarengo, Silvio Aprile, Tracey Pirali
, Org. Biomol. Chem.
, 2017
, 15
, 6604
- Inhibitors of gastric acid secretion. D. E. Bays, H. Finch
, Nat. Prod. Rep.
, 1990
, 7
, 409
- Cholecystokinin-1 receptor antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents. E. Lattmann, S. T. Russell, C. H. Schwalbe, A. Shortt, P. N. Balaram, E. Theochari, M. Alharbi, R. Narayanan, P. Lattmann
, Med. Chem. Commun.
, 2016
, 7
, 1138
- Preparation and characterization of tripeptide chiral stationary phases with varying amino acid sequences and terminal groups. Yang Li, Denggao Jiang, Deyou Huang, Mingxian Huang, Lianjie Li
, Anal. Methods
, 2015
, 7
, 3772
- Selective pericellular hydrogelation by the overexpression of an enzyme and a membrane receptor. Yuhan Wang, Jie Zhan, Yumiao Chen, Sifan Ai, Liantao Li, Ling Wang, Yang Shi, Junnian Zheng, Zhimou Yang
, Nanoscale
, 2019
, 11
, 13714
- Cholecystokinin-2/gastrin antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease. E. Lattmann, J. Sattayasai, R. Narayanan, N. Ngoc, D. Burrell, P. N. Balaram, T. Palizdar, P. Lattmann
, Med. Chem. Commun.
, 2017
, 8
, 680
- Chapter 14. Peptides. C. E. Dempsey
, Annu. Rep. Prog. Chem., Sect. B: Org. Chem.
, 1984
, 81
, 353